Ervebo (rVSV-ZEBOV) Vaccine

Type: vaccine

Status: FDA Approved, EMA Approved, WHO Prequalified

Developer: Merck & Co.

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026